Fingolimod Fty720 | List of Frontiers open access articles

Original Research

Published on 02 Feb 2021

The Therapeutic Targets of Fingolimod (FTY720) Are Involved in Pathological Processes in the Frontal Cortex of Alzheimer's Disease Patients: A Network Pharmacology Study

in Alzheimer's Disease and Related Dementias

Pengqi Yin
Yang Xue
Tingting Wang
Di Zhong
Guozhong Li

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2021.609679

8,607 views
22 citations

Original Research

Published on 15 Sep 2017

Sphingosine 1-Phosphate Receptor Modulator Fingolimod (FTY720) Attenuates Myocardial Fibrosis in Post-heterotopic Heart Transplantation

in Cardiovascular and Smooth Muscle Pharmacology

Naseer Ahmed
Daniele Linardi
Nazeer Muhammad
Cristiano Chiamulera
Guido Fumagalli
Livio San Biagio
Mebratu A. Gebrie
Muhammad Aslam
Giovanni Battista Luciani
Giuseppe Faggian

Frontiers in Pharmacology

doi 10.3389/fphar.2017.00645

6,354 views
40 citations

Hypothesis and Theory

Published on 26 Aug 2016

Mechanism of Action and Clinical Potential of Fingolimod for the Treatment of Stroke

in Neurocritical and Neurohospitalist Care

Wentao Li
Haoliang Xu
Fernando D. Testai

Frontiers in Neurology

doi 10.3389/fneur.2016.00139

8,922 views
32 citations

Original Research

Published on 05 Feb 2019

Combination Therapy With Fingolimod and Neural Stem Cells Promotes Functional Myelination in vivo Through a Non-immunomodulatory Mechanism

in Cellular Neurophysiology

Yuan Zhang
Xin-Yu Lu
Ze-Qin Ye
Bogoljub Ciric
Cun-Gen Ma
Abdolmohamad Rostami
Xing Li
Guang-Xian Zhang

Frontiers in Cellular Neuroscience

doi 10.3389/fncel.2019.00014

4,241 views
8 citations

Original Research

Published on 28 Jan 2020

Fingolimod Augments Monomethylfumarate Killing of GBM Cells

in Neuro-Oncology and Neurosurgical Oncology

Paul Dent
Laurence Booth
Jane L. Roberts
Andrew Poklepovic
John F. Hancock

Frontiers in Oncology

doi 10.3389/fonc.2020.00022

6,128 views
12 citations

Original Research

Published on 08 Jan 2021

Acute Treatment With Fingolimod Does Not Confer Long-Term Benefit in a Mouse Model of Intracerebral Haemorrhage

in Neuropharmacology

Andrea C. Diaz Diaz
Jennifer A. Shearer
Kyle Malone
Christian Waeber

Frontiers in Pharmacology

doi 10.3389/fphar.2020.613103

4,297 views
11 citations

Original Research

Published on 19 Mar 2021

Nanofiber-Based Delivery of Bioactive Lipids Promotes Pro-regenerative Inflammation and Enhances Muscle Fiber Growth After Volumetric Muscle Loss

in Tissue Engineering and Regenerative Medicine

Cheryl L. San Emeterio
Lauren A. Hymel
Thomas C. Turner
Molly E. Ogle
Emily G. Pendleton
William Y. York
Claire E. Olingy
Alan Y. Liu
Hong Seo Lim
Todd A. Sulchek

Frontiers in Bioengineering and Biotechnology

doi 10.3389/fbioe.2021.650289

6,481 views
16 citations

Original Research

Published on 14 Jan 2021

FTY720 Prevents Spatial Memory Impairment in a Rat Model of Chronic Cerebral Hypoperfusion via a SIRT3-Independent Pathway

in Cellular and Molecular Mechanisms of Brain-aging

Miao Zhang
Yuan Hu
Jiahui Zhang
Junjian Zhang

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.593364

8,006 views
21 citations

Articles

The Therapeutic Targets of Fingolimod (FTY720) Are Involved in Pathological Processes in the Frontal Cortex of Alzheimer's Disease Patients: A Network Pharmacology Study

Sphingosine 1-Phosphate Receptor Modulator Fingolimod (FTY720) Attenuates Myocardial Fibrosis in Post-heterotopic Heart Transplantation

Mechanism of Action and Clinical Potential of Fingolimod for the Treatment of Stroke

Combination Therapy With Fingolimod and Neural Stem Cells Promotes Functional Myelination in vivo Through a Non-immunomodulatory Mechanism

Fingolimod Augments Monomethylfumarate Killing of GBM Cells

Acute Treatment With Fingolimod Does Not Confer Long-Term Benefit in a Mouse Model of Intracerebral Haemorrhage

Nanofiber-Based Delivery of Bioactive Lipids Promotes Pro-regenerative Inflammation and Enhances Muscle Fiber Growth After Volumetric Muscle Loss

FTY720 Prevents Spatial Memory Impairment in a Rat Model of Chronic Cerebral Hypoperfusion via a SIRT3-Independent Pathway